Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Smallcap84on Dec 21, 2018 12:11pm

107 Views

Post# 29146690

RE:RE:RE:RE:RE:RE:RE:Project #2800145

In my opinion theres only two reasons the p.p didn't get filled (1)There was a complete lack of interest(which I don't believe) or (2)There was another "developement" that caused them to cancel the p.p before it was filled...I have personally in over 20 years of trading never seen a purposed p.p close so far off its initial goal.....This is either good or bad depending on the reasons.We will know soon enough....

Bullboard Posts

TELUS adds 347K customers in Q3